Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Nexavar

- PMLiVE

NHS increases COVID-19 testing capacity, FDA halts foreign inspections

New measures to tackle the novel coronavirus announced across the Atlantic

- PMLiVE

Doctors worried NHS is unprepared for coronavirus as government unveils action plan

Concerns raised as government reveals key planning document

Novartis day

Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD

New drug due for launch in Europe in the second quarter

- PMLiVE

NHS reliance on ‘short-term measures’ has made it financially unstable, auditors report

Quick fixes are draining funding for long-term investment

- PMLiVE

NICE plans to widen the net for data it uses in guidance

Plans to include electronic health records and real-world evidence

AstraZeneca AZ

AZ’s Imfinzi scores orphan drug status in liver cancer

Company is looking to gain approval in the first-line advanced setting

- PMLiVE

Novartis links up with NHS for speedy access to cholesterol drug inclisiran

Collaboration will see drug offered to patients across the UK via clinical study

Bayer symbol

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

If approved candidate would become a first-in-category therapy

Bayer symbol

Bayer extends alliance with Evotec in women’s health

Five-year research agreement focuses on polycystic ovary syndrome

- PMLiVE

Health research crisis in the NHS is putting patient care at risk

New report highlights importance of research in the health service

- PMLiVE

NHS plans to cut certain routine tests as part of cost-saving efforts

Under proposed plans tests will only be used in exceptional situations

- PMLiVE

Labour clashes with government on ‘NHS for sale’ claims

Government maintains NHS will remain off the table in negotiations

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links